![Jerome Dvonch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jerome Dvonch
Directeur Financier/CFO chez
SONOMA PHARMACEUTICALS, INC.
Fortune : 4 821 $ au 31/05/2026
Profil
Jerome J.
Dvonch currently works at Sonoma Pharmaceuticals, Inc., as Chief Financial Officer from 2023.
Mr. Dvonch also formerly worked at Protein Design Labs, Inc., as Associate Director-Financial Planning & Analysis from 2004 to 2005, NeoGenomics, Inc., as Chief Accounting Officer & Finance Director in 2011, Exelixis, Inc., as Associate Director-Financial Analysis & Reporting from 2000 to 2004, NeoGenomics Laboratories, Inc., as Director-Finance & External Reporting from 2005 to 2015, PharmChem, Inc., as Manager-Business Analysis, Sonoma Pharmaceuticals, Inc., as Chief Financial Officer from 2020 to 2022, and Spine Center Atlanta, as Controller, SVP-Finance & Accounting.
Mr. Dvonch received his Masters Business Admin degree from Rochester Christian University and undergraduate degree from Niagara University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/04/2026 | 4 229 ( 0,12 % ) | 4 821 $ | 31/05/2026 |
Postes actifs de Jerome Dvonch
| Sociétés | Poste | Début |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 07/04/2023 |
Anciens postes connus de Jerome Dvonch
| Sociétés | Poste | Fin |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 03/10/2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Directeur Financier/CFO | 01/07/2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 01/07/2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/06/2004 |
Spine Center Atlanta
 Spine Center Atlanta Medical/Nursing ServicesHealth Services Operates as a spine and orthopedic care treatment center | Comptroller/Controller/Auditor | - |
Formation de Jerome Dvonch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
32
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
PharmChem, Inc.
 PharmChem, Inc. Medical/Nursing ServicesHealth Services Provides integrated drug testing services | Health Services |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Sonoma Pharmaceuticals, Inc.
 Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid | Health Technology |
Niagara University
 Niagara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Health Services |
Spine Center Atlanta
Spine Center Atlanta Medical/Nursing ServicesHealth Services Operates as a spine and orthopedic care treatment center | Health Services |
